. 2010 May 20;13(5):500–505. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2010.05.22

2.

肺癌组、肺部良性疾病组、健康对照组TPS、CEA、Pro-GRP和CYFRA21-1治疗前的比较

Pre-treatment comparison of TPS, CEA, Pro-GRP and CYFRA21-1 in patients with lung cancer, pulmonary benign diseases and health control

Group	n	TPS		CEA		Pro-GRP		CYFRA21-1
		n (%)	Concentration (U/L)	n (%)	Concentration (ng/L)	n (%)	Concentration (pg/mL)	n (%)	Concentration (ng/mL)
Compared with pulmonary benign diseases group: ^P<0.001, ^P<0.05, ^**P>0.05; Compared with health control group: ^#P<0.001, ^##P<0.05, ^###P>0.05.
Lung caner	82	45 (54.9)^*#	149.25±130.97^*#	25 (30.5)^**#	13.54±22.12^**##	16 (19.5)^**##	119.63±267.70^**##	5 (6.1)^***###	1.01±1.21^***###
Pulmonary benign diseases	24	1 (3.3)	52.31±21.65	0 (0)	1.33±1.19	0 (0)	11.12±10.89	0	0.88±0.71
Health control	30	1 (3.3)	47.44±19.21	0 (0)	1.55±1.17	0 (0)	10.44±9.83	0	0.67±0.56